Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma-Reference-Cited by-全球学者库

Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma

Published:2019-08-13 Issue:6 Volume:146 Page:1741-1753
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Han Jun¹²³,Han Min‐lu²,Xing Hao¹,Li Zhen‐li¹,Yuan Dao‐yi²,Wu Han¹,Zhang Han¹,Wang Ming‐da¹,Li Chao¹,Liang Lei¹,Song Yan‐yan⁴,Xu Ai‐jing⁵,Wu Meng‐chao¹,Shen Feng¹,Xie Ying²,Yang Tian¹^ORCID

Affiliation:

1. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery HospitalSecond Military Medical University Shanghai China

2. Department of Pharmacology and Chemical BiologyShanghai Jiao Tong University School of Medicine Shanghai China

3. Department of Hepatobiliary SurgeryChinese PLA General Hospital Beijing China

4. Department of Pharmacology and BiostatisticsShanghai Jiao Tong University School of Medicine Shanghai China

5. Department of Infectious Disease, Changhai HospitalSecond Military Medical University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32599

Reference48 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma

3. Hepatocellular carcinoma

4. Management of hepatocellular carcinoma: An update

5. Update on Biomarkers of Hepatocellular Carcinoma

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid Biopsy for Early Diagnosis of Hepatocellular Carcinoma: Current State and Future Perspectives;Current Chinese Science;2023-12

2. DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma;Scientific Reports;2023-11-03

3. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8⁺ T cells;Clinical and Translational Medicine;2023-11

4. DNA damage repair-related gene signature can influence immune status and predict prognosis in hepatocellular carcinoma;2023-08-08

5. Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review;Cancer Epidemiology, Biomarkers & Prevention;2023-07-06